A study on bladder cancer validated that by competing with PHLPP2 (PH domain and leucine-rich repeat protein phosphatase 2) mRNA to bind miR-27a, thereby promoting the expression of PHLPP2, MEG3 can restrain the invasion and metastasis of bladder cancer cells (103). This evidence concerns the gene PHLPP2 and urinary bladder cancer.